Technical Analysis for CSLLY - CSL Limited

Grade Last Price % Change Price Change
C 93.56 -3.61% -3.5000
CSLLY closed down 3.61 percent on Wednesday, May 18, 2022, on 60 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Gapped Down Weakness 0.00%
20 DMA Support Bullish -3.61%
Cup with Handle Other -3.61%
Gapped Down Weakness -3.61%
Fell Below 50 DMA Bearish -3.30%
20 DMA Support Bullish -3.30%
MACD Bullish Signal Line Cross Bullish -3.30%
Cup with Handle Other -3.30%
Gapped Down Weakness -3.30%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

CSL Limited Description

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza vaccines. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medical Specialties Anatomy Alpha Influenza Neurological Disorders Disorders Blood Angioedema Complement Deficiency Hereditary Angioedema Antitrypsin Deficiency Behring Biopharmaceutical And Allied Biopharmaceutical And Allied Products Bleeding Disorders Blood Plasma Csl Csl Behring Csl Limited Non Plasma Biotherapeutic Products Treatment Of Immunodeficiency

Is CSLLY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 117.49
52 Week Low 85.07
Average Volume 56,401
200-Day Moving Average 103.4832
50-Day Moving Average 97.6450
20-Day Moving Average 95.8290
10-Day Moving Average 95.1175
Average True Range 3.0394
RSI 43.18
ADX 8.82
+DI 25.2897
-DI 27.9521
Chandelier Exit (Long, 3 ATRs) 91.5918
Chandelier Exit (Short, 3 ATRs) 101.1482
Upper Bollinger Bands 99.4514
Lower Bollinger Band 92.2066
Percent B (%b) 0.19
BandWidth 7.5601
MACD Line -0.6536
MACD Signal Line -0.6679
MACD Histogram 0.0143
Fundamentals Value
Market Cap 85.16 Billion
Num Shares 910 Million
EPS 2.92
Price-to-Earnings (P/E) Ratio 32.01
Price-to-Sales 8.90
Price-to-Book 11.58
PEG Ratio 0.00
Dividend 2.11
Dividend Yield 2.26%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 97.8500
Resistance 3 (R3) 98.2633 97.2467 97.1350
Resistance 2 (R2) 97.2467 96.1541 97.0400 96.8965
Resistance 1 (R1) 95.4033 95.4792 94.8950 94.9900 96.6582
Pivot Point 94.3867 94.3867 94.1325 94.1800 94.3867
Support 1 (S1) 92.5433 93.2941 92.0350 92.1300 90.4618
Support 2 (S2) 91.5267 92.6192 91.3200 90.2235
Support 3 (S3) 89.6833 91.5267 89.9850
Support 4 (S4) 89.2700